drugset / Trial / NCT00619385
A Safety and Pharmacokinetic Study of Proellex®
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Dose escalating study of 7 daily doses of Proellex at 100 mg, 150 mg and 200 mg
Timeline
- Start
- 2008-02
- Primary completion
- 2008-09
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telapristone Acetate | Other / unclassified | 100 mg | — |
| Subject | Telapristone Acetate | Other / unclassified | 150 mg | — |
| Subject | Telapristone Acetate | Other / unclassified | 200 mg | — |
Indications
No indication recorded.